• Globe Newswire

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Y-mAbs

SAN FRANCISCO, March 11, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) investors who suffered significant losses...